Steric hindrance of antibody binding in an Omicron spike fusion intermediate
- 6 May 2026
- journal article
- Published by Springer Nature in Nature
- Vol. 654 (8119) , 762-770
Abstract
Understanding conformational changes of the coronavirus spike protein is critical for developing broad-spectrum therapies. The pan-coronavirus epitope spike residues 815-825 (centred on the S2' site) are buried in the prefusion spike but are transiently exposed upon ACE2 binding1,2. Here, using integrated functional and structural analyses, we demonstrate that 76E1, an antibody targeting spike residues 815-825, specifically recognizes an open early fusion intermediate conformation in which this epitope adopts a helical conformation, designated the S2'-helix. SARS-CoV-2 Omicron variants evade such antibodies via steric hindrance resulting from S2'-helix shifts and restricted S1-ACE2 distancing in the early fusion intermediate conformation, together with increased reliance on cathepsin-mediated entry that impairs 76E1 inhibition of S2' cleavage. The H655Y mutation is central to this evasion. Antibody size directly affects its access to the S2'-helix. Crucially, antibody size minimization reversed the evasion mechanisms and significantly enhanced neutralizing activity against authentic Omicron variants and other human coronaviruses, including SARS-CoV-1 and HCoV-229E. These findings establish small-molecule targeting of the S2'-helix as a strategy for pan-coronavirus therapies.Keywords
This publication has 49 references indexed in Scilit:
- Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral targetCell, 2025
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsCell, 2022
- Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodiesScience China Life Sciences, 2022
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2Cell Host & Microbe, 2022
- Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2Cell Host & Microbe, 2022
- Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibodyCell, 2022
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinCell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004